Puma Biotechnology is Now Oversold (PBYI) - Forbes

09-10-2013 ForbesComments (0)

BiotechnologyPuma Biotech

In trading on Wednesday, shares of Puma Biotechnology, Inc. (NYSE: PBYI) entered into oversold territory, hitting an RSI reading of 25.3, after changing hands as low as $38.94 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY ...

Read more on Forbes

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top